Axogen (AXGN) Assets Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.18% |
| Dec 31, 2025 | 4.30% |
| Sep 30, 2025 | 3.44% |
| Jun 30, 2025 | 1.57% |
| Mar 31, 2025 | -0.31% |
| Dec 31, 2024 | -0.69% |
| Sep 30, 2024 | -2.94% |
| Jun 30, 2024 | -3.54% |
| Mar 31, 2024 | -1.87% |
| Dec 31, 2023 | -0.76% |
| Sep 30, 2023 | 0.12% |
| Mar 31, 2023 | 9.36% |
| Dec 31, 2022 | 8.11% |
| Sep 30, 2022 | 8.24% |
| Jun 30, 2022 | 7.78% |
| Mar 31, 2022 | 7.26% |
| Dec 31, 2021 | 9.10% |
| Sep 30, 2021 | 9.11% |
| Jun 30, 2021 | 9.46% |
| Mar 31, 2021 | 52.94% |
| Dec 31, 2020 | 50.67% |
| Sep 30, 2020 | 66.22% |
| Mar 31, 2020 | 49.60% |
| Dec 31, 2019 | 49.41% |
| Sep 30, 2019 | 71.12% |
| Jun 30, 2019 | 70.22% |
| Mar 31, 2019 | 68.58% |
| Dec 31, 2018 | 63.42% |
| Sep 30, 2018 | 58.09% |
| Jun 30, 2018 | 84.84% |
| Mar 31, 2018 | 25.16% |
| Dec 31, 2017 | 53.12% |
| Sep 30, 2017 | 28.08% |
| Jun 30, 2017 | 24.06% |
| Mar 31, 2017 | 20.77% |
| Dec 31, 2016 | 18.75% |
| Sep 30, 2016 | 1.12% |
| Jun 30, 2016 | 26.53% |
| Mar 31, 2016 | 23.34% |
| Dec 31, 2015 | 21.96% |
| Sep 30, 2015 | 61.61% |
| Jun 30, 2015 | 37.23% |
| Mar 31, 2015 | 39.00% |
| Dec 31, 2014 | 9.49% |
| Sep 30, 2014 | 11.65% |
| Jun 30, 2014 | 22.58% |
| Dec 31, 2013 | 62.89% |